This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

The assiged 510k) number is Ko9a570

Company: Horiba ABX SAS Parc Euromédecine Rue du Caducée - BP 7290 34184 Montpellier cedex 4 FRANCE Telephone: + (33) 4 67 14 18 43 Fax: + (33) 4 67 14 18 75

Contact Person: Carolinc Ferrer (caroline.ferrer@horiba.com)

Date Prepared: $1 1 ^ { \mathfrak { t h } }$ August 2009

# Device Name:

The following calibrator is for use in conjunction with the ABX PENTRA 400, cleared to market under K052007.

# CALIBRATOR:

Tradc/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
ABX PENTRA TPU Cal   
Urine calibrator   
Class II   
$\ S 8 6 2 . 1 1 5 0$ : Calibrator   
JIT ; Calibrator, Secondary

# Substantial Equivalence:

The data and information supplied in this submission demonstrates substantial equivalence to the predicate device:

<table><tr><td>Submission device</td><td>Substantially equivalent Predicate device</td></tr><tr><td>ABX PENTRA TPU Cal Horiba ABX SAS</td><td>ABX PENTRA Urine Cal Horiba ABX SAS K071779</td></tr></table>

# Description:

The calibrator included in this submission is for use on the ABX PENTRA 400 (K052007), which is a discrete photometric benchtop clinical chemistry analyzer

The ABX PENTRA TPU Cal is a liquid calibrator based on a buffered aqueous solution, containing human serum. The assigned values of the calibrator components are given on the calibrator vials, ensuring optimal calibration of the appropriate HORIBA ABX methods on the ABX PENTRA 400 analyzer. This calibrator is provided in three vials of $3 ~ \mathrm { m l }$

# Intended Use:

ABX Pentra TPU Cal is used to calibrate total proteins in urine measurement with reagent ABX Pentra Urinary Proteins CP on ABX PENTRA 400 analyzer.

# CALIBRATOR

<table><tr><td rowspan=1 colspan=2>ABX PENTRA TPU Cal:                                       •</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Total Proteins in urine</td></tr><tr><td rowspan=1 colspan=1>FormatStability</td><td rowspan=1 colspan=1>Liquid with chemical additives and materials of biologicaloriginClosed stability: 24 months at 2-8°COpen stability: 9 weeks at 2-8°C</td></tr></table>

# Conclusions for Performance Testing :

The performance testing data conclude that the safety and effectiveness of the device are not compromised, and that they met all acceptance criteria, demonstrating that the devicc is substantially equivalent to the predicate device.

Horiba ABX SAS, Inc.   
c/o Ms. Caroline Ferrer   
Regulatory Affairs Specialist   
Parc Euromedecine Rue Du Caducee, BP 7290   
34184 Montpellier Cedex 4, France

# OCT 1 6 2009

Re: k092570 Trade Name: ABX PENTRA TPU Cal Regulation Number: 21 CFR $\ S 8 6 2 . 1 1 5 0$ Regulation Name: Calibrator Regulatory Class: Class II Product Codes: JIT Dated: August 18, 2009 Received: August 21, 2009

Dear Ms. Ferrer:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing o devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class  (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address hittp://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Cc

Courtnby C. Harper, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

# Indication for Use

510k) Number (Iknow): K90570

Device Name: ABX PENTRA TPU Cal

Indication For Use:

The ABX PENTRA Urine Cal is a calibrator for use in the calibration of the quantitative method : ABX PENTRA Urinary Proteins CP on ABX PENTRA 400 clinical chemistry analyzer as specified on the vials.

# Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/e5c9e8dde257ba54cafbd91963ea76461feb9f5e748592438729753c620b977c.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety